亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢東康源精細化學品有限公司  

醫藥中間體 原料藥 食品添加劑

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:黃小姐
  • 電話:027-81302208
  • 郵件:dkyamy@163.com
  • 傳真:027-81302208
  • QQ:903291902
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 現貨供應廠家扎萊普隆
現貨供應廠家扎萊普隆
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2014-03-03 14:50
 
詳細信息
     對扎萊普隆原料藥價格、扎萊普隆原料藥廠家、扎萊普隆原料藥作用還有深深的疑惑嗎?接下來由扎萊普隆原料藥生產廠家東康源傾情為您解惑。
 一.東康源友情為您提供的扎萊普隆原料藥的基本介紹:
1.中文名稱:扎萊普隆
2.中文別名:扎雷普隆
3.化學名稱:N-乙基-N-3-[7-(3-***基吡唑并[1,5a]嘧啶基)苯基]乙酰胺
4.英文名稱:Zaleplon/n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
 
二.東康源還精心為您準備了扎萊普隆原料藥的詳細物化性質介紹:    
1.cas 號:151319-34-5
2.分子式:C17H15N5O
3.分子量:305.3339
4.性  狀:白色結晶粉末
5.作  用:用于鎮靜、**
  
   東康源原則上建議各位采購商購買由大廠家東康源生產供應的扎萊普隆原料藥!我們鄭重承諾“相同質量的扎萊普隆原料藥,我們價格最好;相同價格的扎萊普隆原料藥,我們質量最好!”
©2025 武漢東康源精細化學品有限公司 版權所有   技術支持:化工網   訪問量:22416  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |